drugset / Trial / NCT00219622

A Phase 2 Study of the Safety and Efficacy of a Tofimilast in Adult Patients With Chronic Obstructive Pulmonary Disease

NCT00219622 ↗

Phase 2 Completed 300 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

This an initial proof of concept, phase to study to assess the safety and efficacy of tofimilast for the chronic maintenance treatment of adults with Chronic Obstructive Pulmonary Disease

Timeline

Start
2004-05
Primary completion
2005-07
Completion
2005-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Tofimilast Small molecule — —